Provided by Tiger Trade Technology Pte. Ltd.

Amphastar Pharmaceuticals

25.35
-0.4600-1.78%
Post-market: 25.350.00000.00%19:30 EDT
Volume:530.99K
Turnover:13.56M
Market Cap:1.08B
PE:15.03
High:26.02
Open:25.60
Low:25.30
Close:25.81
52wk High:29.52
52wk Low:16.65
Shares:42.54M
Float Shares:30.52M
Volume Ratio:0.93
T/O Rate:1.74%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.69
EPS(LYR):2.03
ROE:10.30%
ROA:5.11%
PB:1.40
PE(LYR):12.49

Loading ...

Dec 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 25, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Nov 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 24, 2025

Major Issues Report

Form 8-K - Current report
Oct 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 18, 2025

Major Issues Report

Form 8-K - Current report
Sep 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2025

Major Issues Report

Form 8-K - Current report
Aug 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2025

Major Issues Report

Form 8-K - Current report
Aug 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 21, 2025

Major Issues Report

Form 8-K - Current report
Jul 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 04, 2025

Major Issues Report

Form 8-K - Current report
Jun 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]